Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: A case-control study in Tehran, Iran

Prostate Cancer and Prostatic Diseases

Volumn 14, Issue 2, 2011, Pages 105-113

  Safarinejad, M R ^a   Shafiei, N ^a   Safarinejad, S H ^a  

^a Private Practice of Urology and Andrology   (Iran)

Author keywords

epidemiology; genetics; glutathione S transferase M1; GSTP1; GSTT1; polymorphism; prostate neoplasm

Indexed keywords

ISOLEUCINE; VALINE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLUTATHIONE S TRANSFERASE M1 GENE; GLUTATHIONE S TRANSFERASE P1 GENE; GLUTATHIONE S TRANSFERASE T1 GENE; HIGH RISK PATIENT; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IRAN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 79956144719     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2010.54     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 (Pubitemid 351521864)
2. Postma R, Schroder FH. Screening for prostate cancer. Eur J Cancer 2005; 41: 825-833 (Pubitemid 40461688)
3. Bosland M. Sex steroids and prostate carcinogenesis integrated, multifactorial working hypothesis. Ann NY Acad Sci 2006; 1089: 168-176 (Pubitemid 47092095)
4. Safarinejad MR. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran. Ann Oncol 2006; 17: 1166-1171 (Pubitemid 43985255)
5. Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran. Int J Urol 2007; 14: 406-411 (Pubitemid 46776209)
6. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85 (Pubitemid 30451850)
7. Hughes C, Murphy A, Martin C, Sheils O, O'Leary J. Molecular pathology of prostate cancer. J Clin Pathol 2005; 58: 673-684 (Pubitemid 40956818)
8. Kvitko K, Nunes JC, Weimer TA, Salzano FM, Hutz MH. Cytochrome P4501A1 polymorphisms in South American Indians. Hum Biol 2000; 72: 1039-1043 (Pubitemid 32152226)
9. Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA et al. Gender, smoking, glutathione S-transferase variants, and bladder cancer incidence: a population based study. Cancer Lett 2005; 219: 63-69
10. Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 10004-10012 (Pubitemid 27171673)
11. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994; 91: 11733-11737 (Pubitemid 24356419)
12. Sivonová M, Waczulíková I, Dobrota D, Matáková T, Hatok J, Racay P et al. Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study. J Exp Clin Cancer Res 2009; 28: 32
13. Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate 2006; 66: 1535-1541 (Pubitemid 44465818)
14. Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate 2006; 66: 146-156 (Pubitemid 43191236)
15. Srivastava DS, Mandhani A, Mittal B, Mittal RD. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int 2005; 95: 170-173 (Pubitemid 350020890)
16. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 2005; 131: 238-242 (Pubitemid 40238940)
17. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N et al. Association of genetic polymorphisms of glutathione-Stransferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 2003; 23: 2897-2902 (Pubitemid 36969831)
18. Kidd LC, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA. Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 2003; 12: 317-320 (Pubitemid 36994087)
19. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, Durocher F, Jackson RA et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001; 11: 325-330 (Pubitemid 32537406)
20. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, Madersbacher S et al. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 2001; 95: 152-155 (Pubitemid 32477229)
21. Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, Moore JH et al. Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer 2009; 9: 397
22. Safarinejad MR, Shafiei N, Safarinejad S. The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J Hum Genet 2010; 55: 565-570
23. Liu YJ, Huang PL, Chang YF, Chen YH, Chiou YH, Xu ZL et al. GSTP1 genetic polymorphism is associated with a higher risk of DNA damage in pesticide-exposed fruit growers. Cancer Epidemiol Biomarkers Prev 2006; 15: 659-666
24. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996; 56: 4108-4110 (Pubitemid 26304998)
25. Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, Wadelius C et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999; 9: 333-340 (Pubitemid 29376377)
26. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes and GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-743 (Pubitemid 27427630)
27. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione Stransferase p locus and association with susceptibility to bladder, testicular, and prostate cancer. Carcinogenesis 1997; 18: 641-644 (Pubitemid 28132446)
28. Lafunte A, Pujol F, Carretero P, Villa JP, Cuchi A. Human glutathione S-transferase m (GSTm) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993; 68: 49-54 (Pubitemid 23054897)
29. Lai MT, Chen RH, Tsai FJ, Wan L, Chen WC. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer. Urol Oncol 2005; 23: 225-229 (Pubitemid 40961933)
30. Lin HJ, Han CY, Bernstein DA, HsiaoW, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994; 15: 1077-1081 (Pubitemid 24156914)
31. Murata M, Shiraishi T, Fukutome K, Watanabe M, Nagao M, Kubota Y et al. Cytochrome P4501A1 and glutathione S transferase M1 genotypes as risk factors for prostate cancer in Japan. Jpn J Clin Oncol 1998; 28: 657-660 (Pubitemid 128523207)
32. Kidd LC, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA. Polymorphisms in glutathione S-transferase (GST-M1, GSTT1 and GST-p1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 2003; 12: 317-320 (Pubitemid 36994087)
33. Steinhoff C, Franke KH, Golka K, Thier R, Römer HC, Rö tzel C et al. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000; 74: 521-526
34. Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ, Malkowicz SB. Glutathione S-transferase-mu (GSTM1) and- theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 283-287 (Pubitemid 29193897)
35. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239-1248 (Pubitemid 34027754)
36. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 1999; 8: 525-532 (Pubitemid 30019692)
37. Shepard TF, Platz EA, Kantoff PW, Nelson WG, Isaacs WB, Freije D et al. No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiology Biomarkers Prev 2000; 9: 1267-1268
38. Luscombe CJ, French ME, Liu S, Saxby MF, Farrell WE, Jones PW et al. Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer. Cancer Detect Prev 2002; 26: 376-380 (Pubitemid 36035383)
39. Mao GE, Morris G, Lu QY, CaoW, Reuter VE, Cordon-Cardo C et al Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 2004; 28: 368-374 (Pubitemid 39471284)
40. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M et al. The prostate: a target for carcinogenicity of 2-amino-1- methyl-6-phenylimidazo[4, 5-b] pyridine (PhIP) derived from cooked foods. Cancer Res 1997; 57: 195-198 (Pubitemid 27036591)
41. Dijkman GA, Debruyne FM. Epidemiology of prostate cancer. Eur Urol 1996; 30: 281-295 (Pubitemid 26362868)
42. Strachen T, Read AP (eds) Genetic mapping of complex characters. 2nd edn. John Wiley & Sons: New York (NY), 1999; p 287, chapter 12
43. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988; 202: 343-361
44. Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 2002; 94: 936-942 (Pubitemid 34778092)
45. Board PG. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet 1981; 33: 36-43 (Pubitemid 11188461)
46. Hickey K, Do KA, Green A. Smoking and prostate cancer. Epidemiol Rev 2001; 23: 115-125 (Pubitemid 32906623)
47. Fowler Jr JE, Sanders J, Bigler SA, Rigdon J, Kilambi NK, Land SA. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5-9.9 ng/ml. J Urol 2000; 163: 1467-1470 (Pubitemid 30226297)
48. Fowler Jr JE, Bigler SA, Farabaugh PB. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/ml. Cancer 2002; 94: 1661-1667 (Pubitemid 34241102)